Open AccessEffect of long-term treatment with fenspiride (Erespal) on clinical and functional status of patients with chronic obstructive lung disease
Author(s) -
A. A. Visel,
E. Yu. Pronina,
I. Yu. Visel,
M. A. Yunusova
Publication year - 2005
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 6
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2005-0-6-92-94
Subject(s) - medicine , copd , drug , obstructive lung disease , pulmonary disease , pharmacology
This open comparative randomized study has shown that fenspiride is an effective and well-tolerated drug while being administered in combined therapy of COPD for 3 to 12 months. The anti-inflammatory action of fenspiride 80 mg t. i. d. significantly reduced cough in COPD patients and enhanced the effect of bronchodilators. Fenspiride (Erespal) can be included in standards of combined treatment of patients with mild, moderate and severe COPD.